Open Navigation

Hectorol Injection Prescribing Information Hectorol Capsules Prescribing Information For U.S. Residents Only

404 Error.

The page you are looking for cannot be found.

Please return to home page.

Indications

  • Hectorol (doxercalciferol) Injection is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.
  • Hectorol capsules are indicated for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease not on dialysis and patients with chronic kidney disease on dialysis.

Important Safety Information

  • You should not take Hectorol if you have a history of abnormally high calcium blood levels (hypercalcemia) or if you have very high vitamin D levels.
  • Overdosage of any form of vitamin D is dangerous and may require emergency attention.
  • Before taking Hectorol, tell your doctor if you have ever had an irregular heartbeat or seizure, or if you are taking any digitalis drugs (or cholestyramine if you are taking Hectorol capsules).
  • Do not take other vitamin D related drugs if you are currently taking Hectorol.
  • It is important for anyone taking Hectorol to talk to their doctor before taking any non-prescription drugs or magnesium-containing antacids, supplements and herbal preparations and to adhere to instructions about following a low phosphorus diet and calcium supplementation.
  • Your doctor should monitor your calcium, phosphorus and PTH levels.
  • Tell your doctor if you experience symptoms of hypercalcemia such as weakness, headache, drowsiness, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain, metallic taste and loss of appetite.
  • Your doctor should check and treat you for nutritional vitamin D deficiency before starting you on Hectorol capsules.
  • The main side effects of treatment with Hectorol injection are hypercalcemia, hyperphosphatemia, and oversuppression of PTH. The main side effects of treatment with Hectorol capsules are hypercalcemia, hyperphosphatemia, hypercalciuria, and oversuppression of PTH. Your doctor may ask you questions to see if you are experiencing any symptoms related to these conditions.
  • During treatment, your doctor may change your dose of Hectorol as well as the dose of your phosphate binder.
  • Common side effects seen in Hectorol-treated patients on dialysis were swelling, headache, ill feeling, nausea/vomiting, dizziness, shortness of breath, itching and slow heartbeat.
  • Common side effects seen in patients taking Hectorol capsules with Stage 3 or Stage 4 chronic kidney disease were infection, chest pain, constipation, indigestion, anemia, dehydration, depression, muscle stiffness, insomnia, tingling, increased cough, shortness of breath and runny/stuffy nose.
  • Tell your doctor if you are pregnant or nursing.
  • This drug should be used with caution if you have impaired liver function.

Please click here for Hectorol Capsules Full Prescribing Information or click here for Hectorol Injection Full Prescribing Information.

The health information contained herein is provided for general education purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

Contact Us

Sanofi US
55 Cambridge Parkway
Cambridge, MA 02142
Toll free: 800-847-0069 Fax: 617-591-5986

IMPORTANT SAFETY INFORMATION
You should not take Hectorol (doxerciferol) if you have a history of abnormally high calcium blood levels (hypercalcemia) or if you have very high vitamin D levels. VIEW MORE